[Pubmed] Minimally Invasive Thymectomy for Myasthenia Gravis Feasibility and Functional Outcomes
Posté : 28 sept. 2026 12:00
Thorac Cardiovasc Surg. 2026 Sep 28. doi: 10.1055/a-2969-6473. Online ahead of print.
ABSTRACT
BACKGROUND: Thymectomy is established for myasthenia gravis (MG), but evidence from nonspecialist general thoracic surgery units is limited. This study evaluates the feasibility and outcomes of thymectomy following an institutional transition from sternotomy to minimally invasive surgery and assesses MG Composite and MG-ADL scores as longitudinal outcome measures.
METHODS: A single-centre retrospective cohort study of 58 consecutive MG-thymectomy patients between 2018 and 2026. The primary outcome was favourable clinical status (complete stable remission or improvement) at one year. Secondary outcomes included complications, length of stay, medication reduction, and changes in MG score. Between-group comparisons across surgical approaches are descriptive and exploratory only.
RESULTS: Surgical approaches were RATS (n=29; 50.0%), VATS (n=22; 37.9%), and sternotomy (n=7; 12.1%). Perioperative mortality was zero. Overall complication rate was 10.3%. A favourable outcome was achieved in 68.9% (95% CI, 57.3-81.9%). Sternotomy was associated with longer hospital stay (median 7 vs 2-3 days; p=0.002). Prednisolone and pyridostigmine were reduced or discontinued in 72.1% and 55.3% of preoperative users, respectively (both p
Source: https://pubmed.ncbi.nlm.nih.gov/4280526 ... 3&v=2.20.1